Precision Oncology

FREE – Gastrointestinal Cancer Drug Development Digital Summit

The Gastrointestinal Cancer Drug Development Summit is the only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies, ADCs, and precision oncology to address the large unmet clinical need in GI cancers. **This meeting is free-to-attend for drug developers, research institutions, and not-for-profit organizations**. Register for your FREE ticket here: https://ter.li/rx5uwc …

FREE – Gastrointestinal Cancer Drug Development Digital Summit Read More »

NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M

What You Should Know: – NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an agreement to acquire precision oncology platform Trapelo Health for $65M. The agreement purchase price of $65 million, consists of $35 million in cash on hand and $30 million in NeoGenomics …

NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M Read More »

Why Cancer Registries are Part of America’s Fight for Racial Equality

Warren A Whyte, Ph.D., VP Scientific Partnerships at ConcertAI According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white …

Why Cancer Registries are Part of America’s Fight for Racial Equality Read More »

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network

What You Should Know: – Syapse raises 68M in equity investment  led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence  through Syapse’s Learning Health Network. – The Syapse Learning Health Network is a global precision oncology data sharing network, improving cancer care across communities by using real-world data to …

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network Read More »

Armed with $270M in capital, Scorpion Therapeutics aims to broaden the reach of precision oncology

Founded in 2020, Scorpion is agnostic about the potential therapies and targets it will explore with what it describes as its drug-hunting engine. But the company is hoping to unveil its first drug candidate this year.

Mission Bio Launches Single-Cell Multi-Omics System for Precision Cancer Therapies

What You Should Know: – Mission Bio launches industry’s first and only single-cell multi-omics platform, is announcing the launch of its most comprehensive instrument to-date, to save the industry billions of dollars in drug development costs and bring life-saving treatments to market at least six months faster. – Mission Bio’s Tapestri Platform, the first single-cell …

Mission Bio Launches Single-Cell Multi-Omics System for Precision Cancer Therapies Read More »

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. – CancerIQ’s technology enables hospitals to use genomics to personalize the prevention and early detection of cancer. – Two …

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform Read More »